255 related articles for article (PubMed ID: 31883101)
1. Treatment decisions in women of childbearing age on valproate.
Harris L; Lowes O; Angus-Leppan H
Acta Neurol Scand; 2020 Apr; 141(4):287-293. PubMed ID: 31883101
[TBL] [Abstract][Full Text] [Related]
2. Valproate risk form-Surveying 215 clinicians involving 4775 encounters.
Angus-Leppan H; Moghim MM; Cock H; Kinton L; Synnott Wells M; Shankar R
Acta Neurol Scand; 2020 Jun; 141(6):483-490. PubMed ID: 32072612
[TBL] [Abstract][Full Text] [Related]
3. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
Vajda FJ; O'Brien TJ; Hitchcock A; Graham J; Lander C
J Clin Neurosci; 2003 Sep; 10(5):543-9. PubMed ID: 12948456
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
[TBL] [Abstract][Full Text] [Related]
5. Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational study.
Cohen MJ; Meador KJ; May R; Loblein H; Conrad T; Baker GA; Bromley RL; Clayton-Smith J; Kalayjian LA; Kanner A; Liporace JD; Pennell PB; Privitera M; Loring DW;
Epilepsy Behav; 2019 Mar; 92():154-164. PubMed ID: 30660966
[TBL] [Abstract][Full Text] [Related]
6. Valproate in the treatment of epilepsy in girls and women of childbearing potential.
Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E
Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171
[TBL] [Abstract][Full Text] [Related]
7. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.
Bhakta J; Bainbridge J; Borgelt L
Epilepsy Behav; 2015 Nov; 52(Pt A):212-7. PubMed ID: 26460786
[TBL] [Abstract][Full Text] [Related]
8. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
[TBL] [Abstract][Full Text] [Related]
9. Managing epilepsy in women of childbearing age.
Crawford PM
Drug Saf; 2009; 32(4):293-307. PubMed ID: 19388721
[TBL] [Abstract][Full Text] [Related]
10. The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre.
Davies P; Reuber M; Grunewald R; Howell S; Dickson J; Dennis G; Shanmugarajah P; Tsironis T; Brockington A
Seizure; 2020 Jul; 79():8-13. PubMed ID: 32380376
[TBL] [Abstract][Full Text] [Related]
11. Women with epilepsy in childbearing age: Pregnancy-related knowledge, information sources, and antiepileptic drugs.
Friedrich L; Sruk A; Bielen I
Epilepsy Behav; 2018 Mar; 80():122-128. PubMed ID: 29414541
[TBL] [Abstract][Full Text] [Related]
12. Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study.
Bosak M; Słowik A; Turaj W
Epilepsy Behav; 2019 Sep; 98(Pt A):1-5. PubMed ID: 31299525
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications.
Jazayeri D; Graham J; Hitchcock A; O'Brien TJ; Vajda FJE
Seizure; 2018 Mar; 56():111-114. PubMed ID: 29471258
[TBL] [Abstract][Full Text] [Related]
14. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Tomson T; Perucca E; Battino D
Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
[TBL] [Abstract][Full Text] [Related]
15. [Position Statement of Hungarian Epilepsy League: The use of valproate preparations for epilepsy in pregnancy and in women of childbearing age].
Janszky J;
Ideggyogy Sz; 2015 Mar; 68(3-4):143. PubMed ID: 26434203
[No Abstract] [Full Text] [Related]
16. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.
Christensen J; Pedersen L; Sun Y; Dreier JW; Brikell I; Dalsgaard S
JAMA Netw Open; 2019 Jan; 2(1):e186606. PubMed ID: 30646190
[TBL] [Abstract][Full Text] [Related]
17. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes.
Veroniki AA; Cogo E; Rios P; Straus SE; Finkelstein Y; Kealey R; Reynen E; Soobiah C; Thavorn K; Hutton B; Hemmelgarn BR; Yazdi F; D'Souza J; MacDonald H; Tricco AC
BMC Med; 2017 May; 15(1):95. PubMed ID: 28472982
[TBL] [Abstract][Full Text] [Related]
18. Level of empowerment and decision-making style of women with epilepsy in childbirth age.
Turner K; Cutica I; Riva S; Zambrelli E; Canevini MP; Pravettoni G
Epilepsy Behav; 2019 Apr; 93():32-37. PubMed ID: 30831399
[TBL] [Abstract][Full Text] [Related]
19. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
Macfarlane A; Greenhalgh T
BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057
[TBL] [Abstract][Full Text] [Related]
20. Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
Johannessen Landmark C; Fløgstad I; Syvertsen M; Baftiu A; Enger U; Koht J; Johannessen SI
Epilepsy Behav; 2019 Sep; 98(Pt A):110-116. PubMed ID: 31330379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]